Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on 65 46 3. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN108409818B reveals a high-yield cytidine synthesis route eliminating tin tetrachloride. Discover cost-effective manufacturing and supply chain advantages for nucleoside intermediates.
Patent CN112480197B reveals a cost-effective route for cytosine nucleoside using cyanoacetaldehyde urea acetal, offering significant supply chain advantages.
Novel 3-step synthesis of Cytosine Nucleoside from cyanoacetaldehyde urea acetal. High yield, cost-effective route for antiviral API manufacturing.